Pediatric asthma and COVID‐19: The known, the unknown, and the controversial
Elissa M. Abrams, Ian Sinha, Ricardo M. Fernandes, Daniel B. Hawcutt
Abstract
The novel coronavirus disease-2019 (COVID-19), caused by the pathogen severe acute respiratory syndrome-CoV-2, is causing a global pandemic, with over 26.9 million cases and 880,000 deaths as of September 6, 2020. While there has been speculation and observational research about the impact of COVID-19 on asthma, much remains unknown. The goal of this article is to provide a scoping review on pediatric asthma and COVID-19 and summarize what we do and do not know from the first wave of the pandemic.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AsthmaBetacoronavirusPandemicPneumoniaMEDLINECoronavirus InfectionsIntensive care medicinePediatricsVirologyOutbreakImmunologyPathologyInternal medicineInfectious disease (medical specialty)DiseaseLawPolitical scienceRespiratory Support and MechanismsCOVID-19 Clinical Research StudiesPediatric Pain Management Techniques